| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/24/2002 | EP1198253A2 Biologically active materials |
| 04/24/2002 | EP1198251A1 Combination of an anti-ep-cam antibody with a chemotherapeutic agent |
| 04/24/2002 | EP1198244A2 Strategy for carbohydrate-based cancer vaccines |
| 04/24/2002 | EP1198235A1 Method of promoting bone growth with hyaluronic acid and growth factors |
| 04/24/2002 | EP1198234A2 Bicyclic aromatic compounds for treating drug addiction |
| 04/24/2002 | EP1198233A1 Sulfonamide and sulfamide substituted imidazoquinolines |
| 04/24/2002 | EP1198232A1 Urea substituted imidazoquinolines |
| 04/24/2002 | EP1198231A1 Bicyclic antagonists selective for the(alpha)v(beta)3 integrin |
| 04/24/2002 | EP1198230A1 Use of creatine or creatine compounds for skin preservation |
| 04/24/2002 | EP1198229A1 Therapeutic agents |
| 04/24/2002 | EP1198228A2 Release of poorly soluble agents |
| 04/24/2002 | EP1198226A1 Mesalazine controlled release oral pharmaceutical compositions |
| 04/24/2002 | EP1198225A1 Epothilone compositions |
| 04/24/2002 | EP1198224A1 Formulations of steroid solutions for inhalatory administration |
| 04/24/2002 | EP1198223A2 Ophthalmic composition comprising ketotifen |
| 04/24/2002 | EP1198222A1 Skin care composition |
| 04/24/2002 | EP1180366A9 Neuronal death inhibitors |
| 04/24/2002 | EP1156787A4 Oxadiazole compounds and compositions for delivering active agents |
| 04/24/2002 | EP1138324A9 Treatment of neurodegenerative conditions with nimesulide |
| 04/24/2002 | EP1051180B1 Phospholipids having antimicrobial activity with the presence of antimicrobials |
| 04/24/2002 | EP1035858B1 Use of ginkgo biloba extracts for preparing a medicine |
| 04/24/2002 | EP0991646B1 An itraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same |
| 04/24/2002 | EP0932407A4 Method for treating migraine pain |
| 04/24/2002 | EP0863911B1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 04/24/2002 | EP0851768B1 Interactive molecular conjugates |
| 04/24/2002 | EP0822813B1 A combination of a 5-ht uptake inhibitor with a selective 5-ht 1a antagonist |
| 04/24/2002 | EP0818992B1 Procedure for encapsulating nsaids |
| 04/24/2002 | EP0801559B1 Process for the preparation of oral dosage-forms containing a beta-lactam antibiotic |
| 04/24/2002 | EP0782568B1 Aromatic ethers derived from indols such as 5ht1-like ligands |
| 04/24/2002 | EP0765126B1 Therapeutic food composition and method to diminish blood sugar fluctuations |
| 04/24/2002 | EP0741970B1 Bactericidal composition |
| 04/24/2002 | EP0714299B1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 04/24/2002 | EP0714298B1 Photosensitiser containing phthalocyanine derivative for photodynamic therapy of tumours |
| 04/24/2002 | EP0628311B1 Xanthine-Derivatives as Antidepressants |
| 04/24/2002 | CN1346406A Human ubiquitin ligase E3 for the modulation of NF-kappa 8 |
| 04/24/2002 | CN1346368A Potassium channel interactors and uses therefor |
| 04/24/2002 | CN1346365A Macrocylic peptides active against the hepatitis C virus |
| 04/24/2002 | CN1346364A 16-hydroxyestratrienes as selective estrogens |
| 04/24/2002 | CN1346362A Avermectin derivatives |
| 04/24/2002 | CN1346360A Phosphoramidate, and mono-di, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-YL)-2-cyclopentene-1-methanol as antiviral agents |
| 04/24/2002 | CN1346356A 治疗性的核苷化合物 Therapeutic nucleoside compound |
| 04/24/2002 | CN1346355A Novel inhibitors of farnesyl-protein transferase |
| 04/24/2002 | CN1346353A Farnesy transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 04/24/2002 | CN1346352A 1-4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 04/24/2002 | CN1346351A 1,2-benzothiazepines for the treatment of hyperlipidemic diseases |
| 04/24/2002 | CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4 |
| 04/24/2002 | CN1346349A Pyrazoelcarboxylic acid derivatives, their preparation, pharmaceutical compositions containing |
| 04/24/2002 | CN1346348A Amide compounds and medicinal use thereof |
| 04/24/2002 | CN1346346A O-thiocarbamoyl-aminoalkanol copmound, their pharmaceutically acceptable salt and process for preparing the same |
| 04/24/2002 | CN1346344A Substituted 2-aminobenzamide caspase ihibitors and the use thereof |
| 04/24/2002 | CN1346343A 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 04/24/2002 | CN1346292A Treatment of thrombosis by combined useof a factor Xa inhibitor and aspirin, tissue plasminogen activator (TPA) a gpII/IIIA antagonist, low molecular weight heparin or heparin |
| 04/24/2002 | CN1346286A Methods and compositions for use in perfusion applications |
| 04/24/2002 | CN1346282A Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as combination therapy method in treating neoplasia |
| 04/24/2002 | CN1346281A Method for a programmed controlled overain simulation protocol |
| 04/24/2002 | CN1346277A Use of a serenoa repens extract for the production of a medicament to treat prostate cancer |
| 04/24/2002 | CN1346275A Treatment of accidental extravasation of anthracyclines |
| 04/24/2002 | CN1346274A Formulation comprising testosteron undecanoate and castor oil |
| 04/24/2002 | CN1346273A Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
| 04/24/2002 | CN1346272A Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 04/24/2002 | CN1346271A Quinazoline derivatives as angiogenesis inhibitors |
| 04/24/2002 | CN1346270A Compositions having improved stability |
| 04/24/2002 | CN1346269A Calcilytic compounds |
| 04/24/2002 | CN1346268A Medicinal compositions for treating lower uropathy |
| 04/24/2002 | CN1346267A Combination preparation for treating malaria |
| 04/24/2002 | CN1346266A Analgesic regimen |
| 04/24/2002 | CN1346262A Antimicrobial wipes which provide improved immediate germ reduction |
| 04/24/2002 | CN1346252A Prolonged release bioadhesive vaginal gel dosage form |
| 04/24/2002 | CN1346236A Method for preparation of pharmaceutical-grade dithiocarbamate |
| 04/24/2002 | CN1345728A Solasodine hydrochlorate and productive method and application in medicine |
| 04/24/2002 | CN1345727A Aqueous soluble steroid compound alkaloid salt, preparation process and medicinal composition containing same |
| 04/24/2002 | CN1345725A Diaze tropihidine indole for treating chronic obstructive disease of lung |
| 04/24/2002 | CN1345721A Process for preparing photoactivated (-) yellow skin amide |
| 04/24/2002 | CN1345588A No-stinking fish-oil composite micro-capsule and preparation process |
| 04/24/2002 | CN1345586A Medicine for relieving itching and detumescence |
| 04/24/2002 | CN1083455C photocurable glycosminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof |
| 04/24/2002 | CN1083453C Fused imidazole derivatives as emultidrug resistance modulators |
| 04/24/2002 | CN1083452C Pyrido (2,3-d) pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation |
| 04/24/2002 | CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 04/24/2002 | CN1083448C 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (D4) |
| 04/24/2002 | CN1083445C Thiodepsipeptides for combating endoparasites and a method for producing the same |
| 04/24/2002 | CN1083443C 吲哚衍生物 Indole derivatives |
| 04/24/2002 | CN1083438C Substituted dismino-1,3,5-triazine derivatives |
| 04/24/2002 | CN1083436C Process for preparing 1-substoituted 4-cyano-1,2,3-triazoles |
| 04/24/2002 | CN1083431C Novel heterocyclic compounds |
| 04/24/2002 | CN1083430C Carbazolone derivatives |
| 04/24/2002 | CN1083429C Substituted alkyldiamine derivatives and their use as tachykinin antagonists |
| 04/24/2002 | CN1083419C Pentanoic acid derivatives, its preparation, medicinal materials having same and use thereof |
| 04/24/2002 | CN1083275C Medicine for treating breast tuomor and carbuncle and preparation method thereof |
| 04/24/2002 | CN1083272C Oral medicine for treating dermatosis |
| 04/24/2002 | CN1083271C Drug for curing stone of urinary system |
| 04/24/2002 | CN1083266C Total parenteral nutrition solution containing water-soluble vitamin B |
| 04/24/2002 | CN1083265C Improved pharmaceutical formulations containing ibuprofen and codeine |
| 04/24/2002 | CN1083264C Pharmaceutical compositions comprising an opiate ant agonist and calcium salts, their use for the treatment of endorphin-mediated pathlogies |
| 04/24/2002 | CN1083263C Use of melatonin for treating patients suffering from drug addiction |
| 04/24/2002 | CN1083262C Composition of L-dopa esters |
| 04/24/2002 | CN1083261C 脑水肿抑制剂 Brain edema inhibitor |
| 04/24/2002 | CN1083260C Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
| 04/24/2002 | CN1083244C Zilpaterol hydrochloride in specific crystallized formits prepn. process and intermediate products used |
| 04/23/2002 | US6376707 Crystal polymorphism of aminoethylphenoxyacetic acid derivative |